5 Best Depressed Stocks to Buy in 2026

In this article, we will list the 5 Best Depressed Stocks to Buy in 2026. Please visit 10 Best Depressed Stocks to Buy in 2026 if you would like to see the extended list and the methodology behind it.

5. Cencora, Inc. (NYSE:COR)

On May 11, 2026, Wells Fargo analyst Stephen Baxter lowered the firm’s price target on Cencora, Inc. (NYSE:COR) to $331 from $429 while maintaining an Overweight rating on the shares. The firm said the magnitude of the slowdown in U.S. healthcare earnings growth was disappointing, though Wells Fargo noted that Cencora’s core growth trends remained generally in line with peers Cardinal Health and McKesson. The firm added that if core growth remains at current levels, the valuation gap versus peers could narrow.

On May 7, 2026, Citi also lowered the firm’s price target on Cencora, Inc. (NYSE:COR) to $355 from $405 while maintaining a Buy rating on the shares. The firm described the company’s fiscal Q2 U.S. healthcare results as disappointing.

On May 6, 2026, Cencora, Inc. (NYSE:COR) reported Q2 adjusted EPS of $4.75, versus the consensus estimate of $4.73. Revenue totaled $78.4B, versus the consensus estimate of $81.04B. President and CEO Robert P. Mauch said the company delivered solid quarterly results as teams continued executing to support customer needs. Mauch added that Cencora’s FY26 guidance reflects the underlying strength of the business and its focus on long-term value creation. The company also said it made progress on debt reduction during the quarter and expects to resume opportunistic share repurchases in the second half of the fiscal year.

Cencora, Inc. (NYSE:COR) sources and distributes pharmaceutical products in the United States and internationally.